+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin



French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin



European Annals of Otorhinolaryngology, Head and Neck Diseases 131(2): 121-129



The French ENT Society (SFORL) created a workgroup to draw up guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin. The present guidelines cover diagnostic and therapeutic management and prevention of head and neck cancer of cutaneous origin in immunodeficient patients, and in particular in transplant patients and those with HIV infection. The present guidelines were based on a critical multidisciplinary reading of the literature. Immunosuppression and its varieties are defined. The usual risk factors for skin cancer and those specific to immunodeficiency are presented. The prevention, assessment and management of cutaneous carcinoma, melanoma, Kaposi's sarcoma and lymphoma are dealt with. The level of evidence of the source studies was assessed so as to grade the various guidelines. When need be, expert opinions are put forward. Immunodeficient patients are at higher risk of head and neck skin tumors. The level of risk depends on the type of deficiency; there is an especially high risk of squamous cell carcinoma in transplant patients and of Kaposi's sarcoma in HIV-positive subjects. Various viruses are associated with skin cancers. Skin tumors are often evolutive in case of immunodeficiency, requiring rapid treatment. Management is generally the same as in immunocompetent subjects and should be discussed in a multidisciplinary team meeting. Immunosuppression may need to be modulated. In organ transplant patients, the only class of immunosuppressants with proven antitumoral efficacy are mTOR inhibitors, particularly in cutaneous squamous cell carcinoma. The rhythm of clinical surveillance should be adapted according to the risk of recurrence. Preventive measures should be undertaken. Skin cancers in immunodeficiency are highly evolutive, requiring the earliest possible treatment. Immunosuppression may need modulating. As the risk of recurrence may be elevated, careful surveillance should be implemented. Preventive measures should also be undertaken.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053301055

Download citation: RISBibTeXText

PMID: 24656876

DOI: 10.1016/j.anorl.2014.02.002


Related references

French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer. European Annals of Otorhinolaryngology, Head and Neck Diseases 132(4): 205-208, 2016

Management of somatic pain induced by head-and-neck cancer treatment: definition and assessment. Guidelines of the French Oto-Rhino-Laryngology- Head and Neck Surgery Society (SFORL). European Annals of Otorhinolaryngology, Head and Neck Diseases 131(4): 243-247, 2015

Management of somatic pain induced by treatment of head and neck cancer: Postoperative pain. Guidelines of the French Oto-Rhino-Laryngology--Head and Neck Surgery Society (SFORL). European Annals of Otorhinolaryngology, Head and Neck Diseases 131(4): 249-252, 2015

Management of somatic pain induced by head and neck cancer treatment: pain following radiation therapy and chemotherapy. Guidelines of the French Otorhinolaryngology Head and Neck Surgery Society (SFORL). European Annals of Otorhinolaryngology, Head and Neck Diseases 131(4): 253-256, 2015

Guidelines of the French Society of Otorhinolaryngology (SFORL), short version. Extension assessment and principles of resection in cutaneous head and neck tumors. European Annals of Otorhinolaryngology, Head and Neck Diseases 131(6): 375-383, 2015

Guidelines (short version) of the French Oto-Rhino-Laryngology--Head and Neck Surgery Society (SFORL) for the management of post-tonsillectomy pain in adults. European Annals of Otorhinolaryngology, Head and Neck Diseases 131(4): 227-232, 2015

French Society of Otorhinolaryngology and Head and Neck Surgery (SFORL) guidelines concerning the role of otorhinolaryngologists in the management of paediatric obstructive sleep apnoea syndrome: Follow-up protocol for treated children. European Annals of Otorhinolaryngology, Head and Neck Diseases 135(6): 427-431, 2018

Diagnostic and therapeutic strategy in Menière's disease. Guidelines of the French Otorhinolaryngology-Head and Neck Surgery Society (SFORL). European Annals of Otorhinolaryngology, Head and Neck Diseases 134(6): 441-444, 2017

Guidelines of the French Society of Otorhinolaryngology (SFORL), short version. Diagnosis of local recurrence and metachronous locations in head and neck oncology. European Annals of Otorhinolaryngology, Head and Neck Diseases 132(5): 287-290, 2016

Guidelines (short version) of the French Otorhinolaryngology - Head and Neck Surgery Society (SFORL) on patient pathway organization in ENT: The therapeutic decision-making process. European Annals of Otorhinolaryngology, Head and Neck Diseases 132(4): 213-215, 2016

Patient information ahead of thyroid surgery. Guidelines of the French Society of Oto-Rhino-Laryngology and Head and Neck Surgery (SFORL). European Annals of Otorhinolaryngology, Head and Neck Diseases 130(6): 363-368, 2014

Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense Campaign. Annals of Oncology 27(10): 1848-1854, 2016

French ENT Society (SFORL) practice guidelines for lymph-node management in adult differentiated thyroid carcinoma. European Annals of Otorhinolaryngology, Head and Neck Diseases 129(4): 197-206, 2013

Management of pulmonary nodules in head and neck cancer patients - Our experience and interpretation of the British Thoracic Society Guidelines. Surgeon 15(4): 227-230, 2016

Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign. Annals of Oncology 25(11): 2115-2124, 2015